Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet’s disease and secondary myelodysplastic syndrome
2018 ◽
Vol 53
(9)
◽
pp. 1214-1217
◽
2006 ◽
Vol 37
(11)
◽
pp. 1061-1063
◽
2006 ◽
Vol 41
(3)
◽
pp. 204
◽
2011 ◽
Vol 51
(1)
◽
pp. 63-65
◽
2007 ◽
Vol 31
(9)
◽
pp. 1321-1323
◽